TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytes. 2004

Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
Department of Pediatrics, Jikei University School of Medicine, Tokyo 105-8461, Japan. makiyama@jikei.ac.jp

Maintenance of telomeres regulates chromosomal stability and cellular mitosis through a checkpoint mechanism. Continuous cell proliferation requires telomerase to maintain chromosomal stability and to counteract the cellular mitotic clock. Importantly, nuclear expression of telomerase activity is required for elongation of telomere sequences. In this study, we show that tumor necrosis factor alpha (TNFalpha) induces telomerase activity in the cytoplasm of peripheral blood lymphocytes (PBL) at 60 min, followed by translocation of activated telomerase to the nucleus at 120 min. Conversely, the phosphoinositol 3-kinase (PI3K) inhibitor wortmannin blocks TNFalpha-induced activation of telomerase, whereas the specific NF-kappaB translocation inhibitor SN-50 blocks TNFalpha-induced nuclear translocation of activated telomerase. These studies suggest that activation and nuclear translocation of telomerase are regulated by PI3K/Akt/NF-kappaB signaling pathways in PBL.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D017346 Protein Serine-Threonine Kinases A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. Protein-Serine-Threonine Kinases,Serine-Threonine Protein Kinase,Serine-Threonine Protein Kinases,Protein-Serine Kinase,Protein-Serine-Threonine Kinase,Protein-Threonine Kinase,Serine Kinase,Serine-Threonine Kinase,Serine-Threonine Kinases,Threonine Kinase,Kinase, Protein-Serine,Kinase, Protein-Serine-Threonine,Kinase, Protein-Threonine,Kinase, Serine-Threonine,Kinases, Protein Serine-Threonine,Kinases, Protein-Serine-Threonine,Kinases, Serine-Threonine,Protein Kinase, Serine-Threonine,Protein Kinases, Serine-Threonine,Protein Serine Kinase,Protein Serine Threonine Kinase,Protein Serine Threonine Kinases,Protein Threonine Kinase,Serine Threonine Kinase,Serine Threonine Kinases,Serine Threonine Protein Kinase,Serine Threonine Protein Kinases
D051057 Proto-Oncogene Proteins c-akt Protein-serine-threonine kinases that contain PLECKSTRIN HOMOLOGY DOMAINS and are activated by PHOSPHORYLATION in response to GROWTH FACTORS or INSULIN. They play a major role in cell metabolism, growth, and survival as a core component of SIGNAL TRANSDUCTION. Three isoforms have been described in mammalian cells. akt Proto-Oncogene Protein,c-akt Protein,AKT1 Protein Kinase,AKT2 Protein Kinase,AKT3 Protein Kinase,Akt-alpha Protein,Akt-beta Protein,Akt-gamma Protein,Protein Kinase B,Protein Kinase B alpha,Protein Kinase B beta,Protein Kinase B gamma,Protein-Serine-Threonine Kinase (Rac),Proto-Oncogene Protein Akt,Proto-Oncogene Protein RAC,Proto-Oncogene Proteins c-akt1,Proto-Oncogene Proteins c-akt2,Proto-Oncogene Proteins c-akt3,RAC-PK Protein,Rac Protein Kinase,Rac-PK alpha Protein,Rac-PK beta Protein,Related to A and C-Protein,c-akt Proto-Oncogene Protein,Akt alpha Protein,Akt beta Protein,Akt gamma Protein,Akt, Proto-Oncogene Protein,Protein, akt Proto-Oncogene,Protein, c-akt Proto-Oncogene,Proteins c-akt1, Proto-Oncogene,Proteins c-akt2, Proto-Oncogene,Proteins c-akt3, Proto-Oncogene,Proto Oncogene Protein Akt,Proto Oncogene Protein RAC,Proto Oncogene Proteins c akt,Proto Oncogene Proteins c akt1,Proto Oncogene Proteins c akt2,Proto Oncogene Proteins c akt3,Proto-Oncogene Protein, akt,Proto-Oncogene Protein, c-akt,RAC PK Protein,RAC, Proto-Oncogene Protein,Rac PK alpha Protein,Rac PK beta Protein,Related to A and C Protein,akt Proto Oncogene Protein,alpha Protein, Rac-PK,c akt Proto Oncogene Protein,c-akt, Proto-Oncogene Proteins,c-akt1, Proto-Oncogene Proteins,c-akt2, Proto-Oncogene Proteins,c-akt3, Proto-Oncogene Proteins

Related Publications

Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
April 1996, Experimental cell research,
Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
September 2008, Biochemical pharmacology,
Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
December 1994, European journal of immunology,
Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
April 2001, Journal of immunology (Baltimore, Md. : 1950),
Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
October 1995, Journal of immunology (Baltimore, Md. : 1950),
Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
December 1988, Cell,
Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
May 2019, The international journal of biochemistry & cell biology,
Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
March 1991, Proceedings of the National Academy of Sciences of the United States of America,
Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
August 1993, Acta physiologica Scandinavica,
Masaharu Akiyama, and Osamu Yamada, and Teru Hideshima, and Takaaki Yanagisawa, and Kentaro Yokoi, and Kohji Fujisawa, and Yoshikatsu Eto, and Hisashi Yamada, and Kenneth C Anderson
November 1996, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!